Form 4 for HCWB HCW Biologics Inc.
Accepted 2021-07-23 00:00:00 ET · period of report 2021-07-22 · accession 0001209191-21-048079 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-23 | 2021-07-22 | HCWB | Byam Rebecca | CFO | P - Purchase | $8.00 | +25.0K | 52.0K | +93% | +$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-22 | P | A | 25,000 | $8.00 | 52,000 | D | — | — | (F1) Represents shares of Common Stock purchased in connection with the Issuer's initial public offering for consideration of $8.00 per share. |